TRU-SENTIMENT · DeltaNeutral
ARQT Trading Analysis - 09/22/2026 03:58 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ARQT (Arcutis Biotherapeutics, Inc. Common Stock) at $28.21. True Sentiment Bullish, delta 40-60 call 95% / put 5%, call $851,310 vs put $45,750. RSI 71.2.
- Symbol
- ARQT
- Price
- $28.21
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-09-22 15:58:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Options flow sentiment is bullish, with a call dollar volume of $851,310 and a put dollar volume of $45,750.
The pure directional positioning suggests near-term bullish expectations.
Key Statistics: ARQT
Fundamental Snapshot
Valuation
| P/E (Trailing) | 123.62 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 31.69 |
Profitability
| EPS (Trailing) | $0.21 |
| EPS (Forward) | N/A |
| ROE | 12.93% |
| Net Margin | 6.15% |
Financial Health
| Revenue (TTM) | $463.98M |
| Debt/Equity | 0.49 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ARQT include:
- Arcutis Biotherapeutics Announces Positive topline results from pivotal trial of roflumilast cream 0.3% for treatment of atopic dermatitis in adults
- Arcutis Biotherapeutics to Present at Upcoming Healthcare Conferences
- Arcutis Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
These headlines suggest potential positive developments in the company's product pipeline and ongoing research, which could impact the stock's performance.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $463,981,000
- Trailing EPS: $0.21
- Trailing P/E: 123.62
- Price-to-Book: 31.69
- Debt-to-Equity: 0.49
- Return on Equity (ROE): 12.93%
The company's high P/E ratio and price-to-book ratio may indicate overvaluation. However, the positive ROE and relatively low debt-to-equity ratio are strengths.
Current Market Position:
Current price: $28.22
Recent price action shows an increase, with the stock reaching a high of $28.29 and a low of $25.69 on September 22, 2026.
Technical Analysis:
Technical Indicators
The RSI indicates overbought conditions, while the MACD shows a bullish signal. The 50-day SMA is at $25.93, which is below the current price.
True Sentiment Analysis (Delta 40-60 Options):
Options flow sentiment is bullish, with a call dollar volume of $851,310 and a put dollar volume of $45,750.
The pure directional positioning suggests near-term bullish expectations.
Key Price Levels:
Key support and resistance levels are observed at $25.93 (50-day SMA) and $28.29 (recent high).
25-Day Price Forecast:
Based on current technical trends, momentum, and indicators, ARQT is projected for $29.50 to $31.00.
This range is based on the current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).
Defined Risk Strategy Recommendations:
Based on the price forecast, recommended defined risk strategies include:
- Bull Call Spread: Buy $30.00 call, sell $32.50 call
- Iron Condor: Sell $27.50 put, buy $25.00 put, sell $30.00 call, buy $32.50 call
These strategies align with the projected price range and offer defined risk.
Risk Factors:
- Technical warning signs: Overbought RSI
- Sentiment divergences: None observed
- Volatility: Recent increase in ATR
These factors could impact the stock's performance and should be monitored.
Summary & Conviction Level:
Overall bias: Bullish
Conviction level: Medium
One-line trade idea: ARQT shows bullish momentum with strong institutional buying.
View ARQT Options Chain